We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

111 hedge funds and large institutions have $526M invested in Voyager Therapeutics in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

397% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $309K

101% more capital invested

Capital invested by funds: $262M → $526M (+$264M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

30% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 33

1.34% less ownership

Funds ownership: 85.56% → 84.22% (-1.3%)

4% less funds holding

Funds holding: 116 → 111 (-5)

23% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 22

Holders
111
Holders Change
-5
Holders Change %
-4.31%
% of All Funds
2.4%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
17
Increased
43
Reduced
33
Closed
22
Calls
$1.54M
Puts
$309K
Net Calls
+$1.23M
Net Calls Change
+$980K

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$25.4M
2
ClearBridge Investments
ClearBridge Investments
New York
+$4.94M
3
BI
BVF Inc
California
+$4.04M
4
EAM
Erste Asset Management
Austria
+$3.13M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.62M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$16.9M
2
HCM
Highline Capital Management
New York
-$9.06M
3
EAM
Eventide Asset Management
Massachusetts
-$4.1M
4
Millennium Management
Millennium Management
New York
-$3.44M
5
GPP
Great Point Partners
Connecticut
-$3.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
American Century Companies
26
American Century Companies
Missouri
$3.67M +$2.17M +166,687 +667%
AGA
27
Altrinsic Global Advisors
Connecticut
$3.63M – – –
FCMI
28
Foresite Capital Management IV
California
$3.4M +$2.32M +177,804 New
FT
29
Fiduciary Trust
Massachusetts
$2.97M – – –
SIM
30
Spark Investment Management
New York
$2.8M +$297K +22,800 +18%
Millennium Management
31
Millennium Management
New York
$2.78M -$3.44M -264,202 -65%
TA
32
Teachers Advisors
New York
$2.67M +$1.17M +89,750 +181%
Charles Schwab
33
Charles Schwab
California
$2.4M +$147K +11,269 +10%
Two Sigma Advisers
34
Two Sigma Advisers
New York
$1.92M +$11.7K +900 +0.9%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.71M +$12.2K +939 +1%
TCIM
36
TIAA CREF Investment Management
New York
$1.57M +$320K +24,543 +43%
Allianz Asset Management
37
Allianz Asset Management
Germany
$1.54M -$10.9K -834 -1%
AA
38
ALPS Advisors
Colorado
$1.5M +$44.2K +3,394 +5%
MSE
39
MUFG Securities EMEA
United Kingdom
$1.34M +$912K +70,000 New
SG Americas Securities
40
SG Americas Securities
New York
$1.29M +$80.8K +6,204 +10%
Prudential Financial
41
Prudential Financial
New Jersey
$1.27M +$3.91K +300 +0.5%
PFGIA
42
Patriot Financial Group Insurance Agency
Massachusetts
$1.16M -$6.85K -526 -0.9%
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$1.11M +$757K +58,145 New
Invesco
44
Invesco
Georgia
$1.08M -$525K -40,270 -42%
Acadian Asset Management
45
Acadian Asset Management
Massachusetts
$890K +$6.11K +469 +1%
AWM
46
Aevitas Wealth Management
Massachusetts
$711K -$145K -11,150 -23%
Citigroup
47
Citigroup
New York
$706K -$1.1M -84,178 -70%
Bank of America
48
Bank of America
North Carolina
$680K +$325K +24,916 +234%
Swiss National Bank
49
Swiss National Bank
Switzerland
$676K – – –
AIM
50
Assured Investment Management
New York
$640K -$128K -9,859 -23%
1
2
3 4 5

VYGR Hedge Fund Activity: Q1 2019 in Review

111 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2019, worth a combined $526M — up 101% from $262M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of VYGR and 17 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 43 added.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $25.4M. The largest seller was Armistice Capital, cutting an estimated $16.9M.

  • 111 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2019, down from 116 in Q4 2018.
  • Funds reported $526M of Voyager Therapeutics stock for Q1 2019, up 101% quarter-over-quarter.
  • 17 funds opened new Voyager Therapeutics positions in Q1 2019 and 22 closed out, a net change of -5 holders.
  • The largest Voyager Therapeutics buyer in Q1 2019 was PFM Health Sciences, an estimated $25.4M added.
  • The largest Voyager Therapeutics seller in Q1 2019 was Armistice Capital, an estimated $16.9M sold.

Based on aggregated 13F filings for Q1 2019.